On 6 February, the ADIS Advisory Board (composed of people with Mild Cognitive Impairment due to Alzheimer’s disease) and the ADIS Young Adults Advisory Board (composed of university students in their early 20s) gathered for the first time. During the meeting, which was facilitated by Soraya Moradi-Bachiller (Public Involvement Officer at Alzheimer Europe, AE) and...Read More
In dementia research, obtaining informed consent presents unique challenges, in part due to participants’ cognitive impairments and fluctuating decision-making capacities. Much of the literature on this important topic has centred on the perspectives of researchers and healthcare professionals, with less focus on individuals with lived experience of dementia (people living with or at risk of...Read More
On 17 January, the third event in the LETHE webinar series, titled “Beyond the Hype: AI in Dementia – From Early Risk Detection to Disease Treatment,” focused on how Artificial Intelligence (AI) is being applied to improve prevention, diagnosis, and treatment. The webinar, moderated by Cindy Birck from Alzheimer Europe attracted over 70 participants and...Read More
On 13-14 January, the ADIS project consortium came together online for their third General Assembly. ADIS stands for “Early Diagnosis of Alzheimer’s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances”. The project is funded by the Joint Programme for Neurodegenerative diseases (JPND) for three years and will conclude at the end...Read More
We are pleased to announce our participation in the third event in the LETHE webinar series. The upcoming session, titled “Beyond the hype: AI in dementia – from early risk detection to disease treatment,” will take place on 17 January from 10.30-11.30am CET. This webinar highlights work among several EU-funded projects, including LETHE, AI-Mind, ADIS...Read More
In this spotlight on early career researchers interview we talk with Sarah Hücker, PostDoc at the Fraunhofer ITEM-R Division Personalized Tumor Therapy in Regensburg, Germany. She develops and automates methods that allow the sequencing of different nucleic acids (DNA, mRNA, miRNA, etc.) of single cells. Scroll down to watch the interview about her work. In...Read More
Sophia Krix from the Fraunhofer SCAI presented a poster entitled “Digitally Assessed Sleep Disturbances for Early Diagnosis of Alzheimer’s disease” at the Alzheimer’s Association International Conference AAIC24 / Technology and Dementia Preconference. Here, she shares her key take-aways from the conference: 🧬 Blood-Based Biomarkers: A Game Changer Blood tests show potential in detecting changes early...Read More
In this podcast Dementia Researcher shares a few selected highlights from the third day of the Alzheimer’s Association International Conference (AAIC) taking place in Philadelphia and Online, 28th July to 1st August. Caitlyn Fastenau, PhD Candidate at University of Texas Health San Antonio, hosts the show with special guests: Balogun Wasiu, Postdoctoral Associate at University...Read More
On 11 July, the members of the ADIS Young Adults Advisory Board (ADIS YA-AB) gathered online. The session was facilitated by Soraya Moradi-Bachiller (Public Involvement Officer at Alzheimer Europe). During the consultation, members of the ADIS YA-AB were asked what their views and opinions are about the materials developed for the brain health campaign (e.g....Read More
On 26 June, members of the ADIS Advisory Board gathered in Luxembourg. The meeting was attended and facilitated by Soraya Moradi-Bachiller (Public Involvement Officer at Alzheimer Europe, AE), Jesús Rodrigo (Confederación Española de Alzheimer, CEAFA) and Ana Diaz (Public Involvement Lead at AE). During the consultation, members of the ADIS Advisory Board and their supporters...Read More
